Sponge derived bromotyrosines: Structural diversity through natural combinatorial chemistry

Natural Product Communications

Volumn 10, Issue 1, 2015, Pages 219-231

  Niemann, Hendrik ^a   Marmann, Andreas ^a   Lin, Wenhan ^b   Proksch, Peter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Aeroplysinin 1; Aerothionin; Bastadin; Bromotyrosine; Dienone; Psammaplin A; Sponges.

Indexed keywords

AEROPLYSININ 1; AEROTHIONIN; BASTADIN; BROMOTYROSINE DERIVATIVE; DIENONE; NATURAL PRODUCT; PSAMMAPLIN A; UNCLASSIFIED DRUG; ACETONITRILE DERIVATIVE; AEROPLYSININ I; BROMOTYROSINE; CYCLOHEXENE DERIVATIVE; DISULFIDE; TYROSINE;

ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOTRANSFORMATION; CALCIUM HOMEOSTASIS; CELL CYCLE ARREST; CELL PROLIFERATION; CELL VIABILITY; CITROBACTER FREUNDII; CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; HEPATITIS C VIRUS; HUMAN; IC50; KLEBSIELLA OXYTOCA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SPONGE (PORIFERA); STRUCTURE ACTIVITY RELATION; VIRUS REPLICATION; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DEVELOPMENT; ECOSYSTEM; METABOLISM;

ACETONITRILES; ANIMALS; CYCLOHEXENES; DISULFIDES; DRUG DISCOVERY; ECOSYSTEM; HUMANS; MOLECULAR STRUCTURE; PORIFERA; TYROSINE;

EID: 84937554092     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1501000143     Document Type: Review

References (117)

1. Gazave E, Lapébie P, Renard E, Vacelet J, Rocher C, Ereskovsky AV, Lavrov DV, Borchiellini C (2010) Molecular phylogeny restores the suprageneric subdivision of homoscleromorph sponges (Porifera, Homoscleromorpha). PloS ONE, 5, e14290
2. Taylor MW, Radax R, Steger D, Wagner M. (2007) Sponge-Associated microorganisms: evolution, ecology, and biotechnological potential. Microbiology and Molecular Biology Reviews, 71, 295-347.
3. Gutt J. (2006) Coexistence of macro-zoobenthic species on the Antarctic shelf: an attempt to link ecological theory and results. Deep Sea Research Part II: Topical Studies in Oceanography, 53, 1009-1028.
4. Hausmann R, Vitello MP, Leitermann F, Syldatk C. (2006) Advances in the production of sponge biomass Aplysina aerophoba-A model sponge for ex situ sponge biomass production. Journal of Biotechnology, 124, 117-127.
5. Webster NS, Taylor MW, Behnam F, Lcker S, Rattei T, Whalan S, Horn M, Wagner M. (2010) Deep sequencing reveals exceptional diversity and modes of transmission for bacterial sponge symbionts. Environmental Microbiology, 12, 2070-2082.
6. Schmitt S, Angermeier H, Schiller R, Lindquist N, Hentschel U. (2008) Molecular microbial diversity survey of sponge reproductive stages and mechanistic insights into vertical transmission of microbial symbionts. Applied and Environmental Microbiology, 74, 7694-7708.
7. Thomas TRA, Kavlekar DP, LokaBharathi PA. (2010) Marine drugs from sponge-microbe association-A review. Marine Drugs, 8, 1417-1468.
8. Mayer AMS, Rodrguez AD, Taglialatela-Scafati O, Fusetani N, 2013, Marine pharmacology in 2009-2011: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; Affecting the immune and nervous systems, and other miscellaneous mechanisms of action. Marine Drugs, 11, 2510-2573
9. Mayer AMS, Glaser KB, Cuevas C, Jacobs RS, Kem W, Little RD, McIntosh JM, Newman DJ, Potts BC, Shuster DE. (2010) The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends in Pharmacological Sciences, 31, 255-265.
10. Sagar S, Kaur M, Minneman KP. (2010) Antiviral lead compounds from marine sponges. Marine Drugs, 8, 2619-2638.
11. Yasuhara-Bell J, Lu Y. (2010) Marine compounds and their antiviral activities. Antiviral Research, 86, 231-240.
12. Teeyapant R, Kreis P, Wray V, Witte L, Proksch P. (1993) Brominated secondary compounds from the marine sponge Verongia aerophoba and the sponge feeding gastropod Tylodina perversa. Zeitschrift fr Naturforschung C. A journal of biosciences, 48, 640-644.
13. Faulkner DJ. (2000) Marine pharmacology. Antonie van Leeuwenhoek, 77, 135-145.
14. Roche J, Rand M, Yagi Y(1951) The presence of monobromotyrosine in gorgonins. Comptes Rendus Chimie, 232, 570-571.
15. Kunze K, Niemann H, Ueberlein S, Schulze R, Ehrlich H, Brunner E, Proksch P, Pée K-Hv. (2013) Brominated skeletal components of the marine demosponges, Aplysina cavernicola and Ianthella basta: Analytical and biochemical investigations. Marine Drugs, 11, 1271-1287.
16. Shin J, Lee HS, Seo Y, Rho JR, Cho KW, Paul VJ. (2000) New bromotyrosine metabolites from the sponge Aplysinella rhax. Tetrahedron, 56, 9071-9077.
17. Bergquist PR, Wells RJ. (1983) Chemotaxonomy of the Porifera: the development and current status of the field. Marine Natural Products: Chemical and Biological Perspectives, 5, 1-50.
18. Shinde PB, Lee YM, Dang HT, Hong J, Lee CO, Jung JH. (2008) Cytotoxic bromotyrosine derivatives from a two-sponge association of Jaspis sp. And Poecillastra sp. Bioorganic & Medicinal Chemistry Letters, 18, 6414-6418.
19. Jiménez C, Crews P. (1991) Novel marine sponge derived amino acids 13. Additional psammaplin derivatives from Psammaplysilla purpurea. Tetrahedron, 47, 2097-2102.
20. Pia IC, Gautschi JT, Wang GYS, Sanders ML, Schmitz FJ, France D, Cornell-Kennon S, Sambucetti LC, Remiszewski SW, Perez LB, Bair KW, Crews P. (2003) Psammaplins from the sponge Pseudoceratina purpurea: Inhibition of both histone deacetylase and DNA methyltransferase. Journal of Organic Chemistry, 68, 3866-3873.
21. Jung JH, Sim CJ, Lee CO. (1995) Cytotoxic compounds from a two-sponge association. Journal of Natural Products, 58, 1722-1726.
22. Quio E, Crews P. (1987) Phenolic constituents of Psammaplysilla. Tetrahedron Letters, 28, 3229-3232.
23. Kim D, Lee IS, Jung JH, Yang SI. (1999) Psammaplin A, a natural bromotyrosine derivative from a sponge, possesses the antibacterial activity against methicillin-resistant Staphylococcus aureus and the DNA gyrase-inhibitory activity. Archives of Pharmacal Research, 22, 25-29.
24. Oh KB, Oh MN, Kim JG, Shin DS, Shin J. (2006) Inhibition of sortase-mediated Staphylococcus aureus adhesion to fibronectin via fibronectinbinding protein by sortase inhibitors. Applied Microbiology and Biotechnology, 70, 102-106.
25. Nicolaou KC, Hughes R, Pfefferkorn JA, Barluenga S. (2001) Optimization and mechanistic studies of psammaplin A type antibacterial agents active against methicillin-resistant Staphylococcus aureus (MRSA). Chemistry -A European Journal, 7, 4296-4310.
26. Leone-Stumpf D. (2001) Synthesis and chromatography of [RuCp]+-labelled diaryl ether peptoids as precursors of the bastadins from the marine sponge Ianthella basta. Combined Faculties for the Natural Sciences and for Mathematics, Ruperto-Carola University of Heidelberg, Germany, PhD thesis
27. Tymiak AA, Rinehart Jr KL. (1981) Biosynthesis of dibromotyrosine-derived antimicrobial compounds by the marine sponge Aplysina fistularis (Verongia aurea). Journal of the American Chemical Society, 103, 6763-6765.
28. Salam KA, Furuta A, Noda N, Tsuneda S, Sekiguchi Y, Yamashita A, Moriishi K, Nakakoshi M, Tsubuki M, Tani H, Tanaka J, Akimitsu N. (2013) Psammaplin A inhibits hepatitis C virus NS3 helicase. Journal of Natural Medicines, 67, 765-772.
29. Tabudravu JN, Eijsink VGH, Gooday GW, Jaspars M, Komander D, Legg M, Synstad B, van Aalten DMF. (2002) Psammaplin A, a chitinase inhibitor isolated from the fijian marine sponge Aplysinella rhax. Bioorganic & Medicinal Chemistry, 10, 1123-1128.
30. Ahn MY, Jung JH, Na YJ, Kim HS. (2008) A natural histone deacetylase inhibitor, psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells. Gynecologic Oncology, 108, 27-33.
31. Pereira R, Benedetti R, Pérez-Rodrguez S, Nebbioso A, Garca-Rodrguez J, Carafa V, Stuhldreier M, Conte M, Rodrguez-Barrios F, Stunnenberg HG, Gronemeyer H, Altucci L, de Lera R. (2012) Indole-derived psammaplin A analogues as epigenetic modulators with multiple inhibitory activities. Journal of Medicinal Chemistry, 55, 9467-9491.
32. Garca J, Franci G, Pereira R, Benedetti R, Nebbioso A, Rodrguez-Barrios F, Gronemeyer H, Altucci L, de Lera AR. (2011) Epigenetic profiling of the antitumor natural product psammaplin A and its analogues. Bioorganic & Medicinal Chemistry, 19, 3637-3649.
33. Kim DH, Shin J, Kwon HJ. (2007) Psammaplin A is a natural prodrug that inhibits class I histone deacetylase. Experimental and Molecular Medicine, 39, 47-55.
34. Baud MGJ, Leiser T, Haus P, Samlal S, Wong AC, Wood RJ, Petrucci V, Gunaratnam M, Hughes SM, Buluwela L, Turlais F, Neidle S, Meyer-Almes FJ, White AJP, Fuchter MJ. (2012) Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets. Journal of Medicinal Chemistry, 55, 1731-1750.
35. Kim HJ, Kim JH, Chie EK, Young PD, Kim IA. (2012) DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity. Radiation Oncology, 7, 39.
36. Mora FD, Jones DK, Desai PV, Patny A, Avery MA, Feller DR, Smillie T, Zhou YD, Nagle DG. (2006) Bioassay for the identification of natural product-based activators of peroxisome proliferator-Activated receptor-γ (PPARγ): The marine sponge metabolite psammaplin A activates PPARγ and induces apoptosis in human breast tumor cells. Journal of Natural Products, 69, 547-552.
37. Shim JS, Lee HS, Shin J, Kwon HJ. (2004) Psammaplin A, a marine natural product, inhibits aminopeptidase N and suppresses angiogenesis in vitro. Cancer Letters, 203, 163-169.
38. Jiang Y, Ahn EY, Ryu SH, Kim DK, Park JS, Yoon HJ, You S, Lee BJ, Lee DS, Jung JH. (2004) Cytotoxicity of psammaplin A from a two-sponge association may correlate with the inhibition of DNA replication. BMC Cancer, 4, 70-77.
39. Kim D, Lee IS, Jung JH, Lee CO, Choi SU. (1999) Psammaplin A, a natural phenolic compound, has inhibitory effect on human topoisomerase II and is cytotoxic to cancer cells. Anticancer Research, 19, 4085-4090.
40. Urbaniak MD, Tabudravu JD, Msaki A, Matera KM, Brenk R, Jaspars M, Ferguson MAJ. (2006) Identification of novel inhibitors of UDP-Glc 4-epimerase, a validated drug target for african sleeping sickness. Bioorganic and Medicinal Chemistry Letters, 16, 5744-5747.
41. Thoms C, Schupp PJ. (2008) Activated chemical defense in marine sponges-A case study on Aplysinella rhax. Journal of Chemical Ecology, 34, 1242-1252.
42. Ortlepp S, Sjgren M, Dahlstrm M, Weber H, Ebel R, Edrada R, Thoms C, Schupp P, Bohlin L, Proksch P. (2007) Antifouling activity of bromotyrosine-derived sponge metabolites and synthetic analogues. Marine Biotechnology, 9, 776-785.
43. Ebel R, Brenzinger M, Kunze A, Gross HJ, Proksch P. (1997) Wound activation of protoxins in marine sponge Aplysina aerophoba. Journal of Chemical Ecology, 23, 1451-1462.
44. Thoms C, Ebel R, Proksch P. (2006) Activated chemical defense in Aplysina sponges revisited. Journal of Chemical Ecology, 32, 97-123.
45. Lipowicz B, Hanekop N, Schmitt L, Proksch P. (2013) An aeroplysinin-1 specific nitrile hydratase isolated from the marine sponge Aplysina cavernicola. Marine Drugs, 11, 3046-3067.
46. Puyana M, Fenical W, Pawlik JR. (2003) Are there activated chemical defenses in sponges of the genus Aplysina from the Caribbean? Marine Ecology Progress Series, 246, 127-135.
47. Fattorusso E, Minale L, Sodano G, Moody K, Thomson RH. (1970) Aerothionin, a tetrabromo-compound from Aplysina aerophoba and Verongia thiona. Journal of the Chemical Society D: Chemical Communications, 12, 752-753.
48. Moody K, Thomson RH, Fattorusso E, Minale LT, Sodano G. (1972) Aerothionin and homoaerothionin: two tetrabromospirocyclohexadienylisoxazoles from Verongia sponges. Journal of the Chemical Society, Perkin Transactions, 1, 18-24.
49. Cimino G, De Stefano S, Minale L. (1975) Occurrence of 4-hydroxyphenylpyruvic acid oxime in the marine sponge Hymeniacidon sanguinea. Experientia, 31, 756-757.
50. Encarnacion-Dimayuga R, Ramirez MR, Luna-Herrera J. (2003) Aerothionin, a bromotyrosine derivative with antimycobacterial activity from the marine sponge Aplysina gerardogreeni (Demospongia). Pharmaceutical Biology, 41, 384-387.
51. Fendert T, Wray V, Van Soest RW, Proksch P. (1999) Bromoisoxazoline alkaloids from the Caribbean sponge Aplysina insularis. Zeitschrift fr Naturforschung C, 54, 246-252.
52. Gochfeld DJ, Kamel HN, Olson JB, Thacker RW. (2012) Trade-offs in defensive metabolite production but not ecological function in healthy and diseased sponges. Journal of Chemical Ecology, 38, 451-462.
53. Shaala LA, Bamane FH, Badr JM, Youssef DTA. (2011) Brominated arginine-derived alkaloids from the Red Sea sponge Suberea mollis. Journal of Natural Products, 74, 1517-1520.
54. Nuez CV, de Almeida EVR, Granato AC, Marques SO, Santos KO, Pereira FR, Macedo ML, Ferreira AG, Hajdu E, Pinheiro US, Muricy G, Peixinho S, Freeman CJ, Gleason DF, Berlinck RGS. (2008) Chemical variability within the marine sponge Aplysina fulva. Biochemical Systematics and Ecology, 36, 283-296.
55. Carney JR, Rinehart KL. (1995) Biosynthesis of brominated tyrosine metabolites by Aplysina fistularis. Journal of Natural Products, 58, 971-985.
56. Putz A, Kloeppel A, Pfannkuchen M, Brummer F, Proksch P. (2009) Depth-related alkaloid variation in Mediterranean Aplysina sponges. Zeitschrift fr Naturforschung C, 64, 279-287.
57. Thoms C, Wolff M, Padmakumar K, Ebel R, Proksch P. (2004) Chemical defense of Mediterranean sponges Aplysina cavernicola and Aplysina aerophoba. Zeitschrift fr Naturforschung C, 59, 113-122.
58. Thoms C, Ebel R, Hentschel U, Proksch P. (2003) Sequestration of dietary alkaloids by the spongivorous marine mollusc Tylodina perversa. Zeitschrift fr Naturforschung C, 58, 426-432.
59. Ebel R, Marin A, Proksch P. (1999) Organ-specific distribution of dietary alkaloids in the marine opisthobranch Tylodina perversa. Biochemical Systematics and Ecology, 27, 769-777.
60. Abou-Shoer MI, Shaala LA, Youssef DTA, Badr JM, Habib AAM. (2008) Bioactive brominated metabolites from the Red Sea sponge Suberea mollis. Journal of Natural Products, 71, 1464-1467.
61. Ankudey FJ, Kiprof P, Stromquist ER, Chang LC. (2008) New bioactive bromotyrosine-derived alkaloid from a marine sponge Aplysinella sp. Planta Medica, 74, 555-559.
62. Fattorusso E, Minale L, Sodano G. (1972) Aeroplysinin-1, an antibacterial bromo-compound from the sponge Verongia aerophoba. Journal of the Chemical Society, Perkin Transactions, 1, 16-18.
63. Chang CW, Weinheimer AJ. (1977) 2-Hydroxy, 3, 5-dibromo, 4-methoxyphenylacetamide. A dibromotyrosine metabolite from Psammoposilla purpurea. Tetrahedron Letters, 18, 4005-4007.
64. Ciminiello P, Costantino V, Fattorusso E, Magno S, Mangoni A, Pansini M. (1994) Chemistry of Verongida sponges, II. Constituents of the Caribbean sponge Aplysina fistularis forma fulva. Journal of Natural Products, 57, 705-712.
65. Ciminiello P, Fattorusso E, Magno S, Pansini M. (1995) Chemistry of Verongida sponges, IV. Comparison of the secondary metabolite composition of several specimens of Pseudoceratina crassa. Journal of Natural Products, 58, 689-696.
66. Teeyapant R, Proksch P. (1993) Biotransformation of brominated compounds in the marine sponge Verongia aerophoba-Evidence for an induced chemical defense? Naturwissenschaften, 80, 369-370.
67. Ciminiello P, Fattorusso E, Forino M, Magno S, Pansini M. (1997) Chemistry of verongida sponges VIII1-bromocompounds from the mediterranean sponges Aplysina aerophoba and Aplysina cavernicola. Tetrahedron, 53, 6565-6572.
68. Ciminiello P, Dell'Aversano C, Fattorusso E, Magno S, Pansini M. (1999) Chemistry of Verongida sponges. 9.1 Secondary metabolite composition of the Caribbean sponge Aplysina cauliformis. Journal of Natural Products, 62, 590-593.
69. Ciminiello P, Dell'Aversano C, Fattorusso E, Magno S, Pansini M. (2000) Chemistry of Verongida sponges. 10.1 Secondary metabolite composition of the Caribbean sponge Verongula gigantea. Journal of Natural Products, 63, 263-266.
70. Saeki BM, Granato AC, Berlinck RGS, Magalhes A, Schefer AB, Ferreira AG, Pinheiro US, Hajdu E. (2003) Two unprecedented dibromotyrosine-derived alkaloids from the Brazilian endemic marine sponge Aplysina caissara. Journal of Natural Products, 65, 796-799.
71. Makarieva TN, Stonik VA, Alcolado P, Elyakov YB. (1981) Comparative study of the halogenated tyrosine derivatives from Demospongiae (Porifera). Comparative Biochemistry and Physiology Part B: Comparative Biochemistry, 68, 481-484.
72. Kreuter MH, Robitzki A, Chang S, Steffen R, Michaelis M, Kljajić Z, Bachmann M, Schrder HC, Mller WE. (1992) Production of the cytostatic agent aeroplysinin by the sponge Verongia aerophoba in in vitro culture. Comparative Biochemistry and Physiology Part C: Comparative Pharmacology, 101, 183-187.
73. Weiss B, Ebel R, Elbrchter M, Kirchner M, Proksch P. (1996) Defense metabolites from the marine sponge Verongia aerophoba. Biochemical Systematics and Ecology, 24, 1-12.
74. Gutiérrez M, Capson TL, Guzmn HM, Gonzlez J, Ortega-Barra E, Quio E, Riguera R. (2005) Antiprotozoal activity against Plasmodium falciparum and Trypanosoma cruzi of aeroplysinin-1 isolated from the new sponge Aplysina chiriquensis. Pharmaceutical Biology, 43, 762-765.
75. Galeano E, Thomas OP, Robledo S, Munoz D, Martinez A. (2011) Antiparasitic bromotyrosine derivatives from the marine sponge Verongula rigida. Marine Drugs, 9, 1902-1913.
76. Koulman A, Proksch P, Ebel R, Beekman AC, van Uden W, Konings AW, Pedersen JA, Pras N, Woerdenbag HJ. (1996) Cytoxicity and mode of action of aeroplysinin-1 and a related dienone from the sponge Aplysina aerophoba. Journal of Natural Products, 59, 591-594.
77. Rodrguez-Nieto S, Gonzlez-Iriarte M, Carmona R, Muoz-Chpuli R, Medina MA, Quesada AR. (2002) Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge. The FASEB Journal, 16, 261-263.
78. Martnez-Poveda B, Rodrguez-Nieto S, Garca-Caballero M, Medina M, Quesada AR. (2012) The antiangiogenic compound aeroplysinin-1 induces apoptosis in endothelial cells by activating the mitochondrial pathway. Marine Drugs, 10, 2033-2046.
79. Crdoba R, Tormo NS, Medarde AF, Plumet J. (2007) Antiangiogenic versus cytotoxic activity in analogues of aeroplysinin-1. Bioorganic & Medicinal Chemistry, 15, 5300-5315.
80. Gonzlez-Iriarte M, Carmona R, Pérez-Pomares JM, Macas D, Medina M, Quesada AR, Muoz-Chpuli R. (2003) A modified chorioallantoic membrane assay allows for specific detection of endothelial apoptosis induced by antiangiogenic substances. Angiogenesis, 6, 251-254.
81. Martnez-Poveda B, Garca-Vilas JA, Cardenas C, Melgarejo E, Quesada AR, Medina MA. (2013) The brominated compound aeroplysinin-1 inhibits proliferation and the expression of key pro-inflammatory molecules in human endothelial and monocyte cells. PloS one, 8, e55203.
82. Kreuter MH, Leake RE, Rinaldi F, Mller-Klieser W, Maidhof A, Mller WE, Schrder HC. (1990) Inhibition of intrinsic protein tyrosine kinase activity of EGF-receptor kinase complex from human breast cancer cells by the marine sponge metabolite (+)-Aeroplysinin-1. Comparative Biochemistry and Physiology Part B: Comparative Biochemistry, 97, 151-158.
83. D'Ambrosio M, Guerriero A, Pietra F. (1984) Novel, racemic or nearly racemic antibacterial bromo and chloroquinols and γ lactams of the verongiaquinol and the cavernicolin type from the marine sponge Aplysina (= Verongia) cavernicola. Helvetica chimica acta, 67, 1484-1492.
84. Sharma GM, Burkholder PR. (1967) Studies on antimicrobial substances of sponges. I. Isolation, purification, and properties of a new brominecontaining antibacterial substance. The Journal of Antibiotics, 20, 200-203.
85. Andersen RJ, Faulkner DJ. (1973) A novel antibiotic from a sponge of the genus Verongia. Tetrahedron Letters, 14, 1175-1178.
86. Sallam AA, Ramasahayam S, Meyer SA, Sayed KAE. (2010) Design, synthesis, and biological evaluation of dibromotyrosine analogues inspired by marine natural products as inhibitors of human prostate cancer proliferation, invasion, and migration. Bioorganic & Medicinal Chemistry, 18, 7446-7457.
87. Gorshkov BA, Shestak OP, Gorshkova IA, Makar'eva TN, Novikov VL, Stonik VA. (1992) Synthesis of verongiaquinol and related compounds and study of their inhibiting action on rat brain Na+, K+-ATPase. Chemistry of Natural Compounds, 28, 128-129.
88. Carroll AR, Kaiser SM, Davis RA, Moni RW, Hooper JN, Quinn RJ. (2010) A bastadin with potent and selective δ-opioid receptor binding affinity from the Australian sponge Ianthella flabelliformis. Journal of Natural Products, 73, 1173-1176.
89. Niemann H, Lin W, Mller WE, Kubbutat M, Lai D, Proksch P. (2012) Trimeric hemibastadin congener from the marine sponge Ianthella basta. Journal of Natural Products, 76, 121-125.
90. Brunner E, Ehrlich H, Schupp P, Hedrich R, Hunoldt S, Kammer M, Machill S, Paasch S, Bazhenov VV, Kurek DV, Arnold T, Brockmann S, Ruhnow M, Born R (2009) Chitin-based scaffolds are an integral part of the skeleton of the marine demosponge Ianthella basta. Journal of Structural Biology, 168, 539-547.
91. Van Wyk AW, Zuck KM, McKee TC. (2011) Lithothamnin A, the first bastadin-like metabolite from the red alga Lithothamnion fragilissimum. Journal of Natural Products, 74, 1275-1280.
92. Bayer M, Hellio C, Maréchal JP, Frank W, Lin W, Weber H, Proksch P. (2011) Antifouling bastadin congeners target mussel phenoloxidase and complex copper (II) ions. Marine Biotechnology, 13, 1148-1158.
93. Hellio C, Bourgougnon N, Gal YL. (2000) Phenoloxidase (EC 1.14. 18.1) from the byssus gland of Mytilus edulis: purification, partial characterization and application for screening products with potential antifouling activities. Biofouling, 16, 235-244.
94. Hertiani T, Edrada-Ebel R, Ortlepp S, van Soest RW, de Voogd NJ, Wray V, Hentschel U, Kozytska S, Mller WE, Proksch P. (2010) From antifouling to biofilm inhibition: New cytotoxic secondary metabolites from two Indonesian Agelas sponges. Bioorganic & Medicinal Chemistry, 18, 1297-1311.
95. Mack MM, Molinski TF, Buck ED, Pessah IN. (1994) Novel modulators of skeletal muscle FKBP12/calcium channel complex from Ianthella basta. Role of FKBP12 in channel gating. Journal of Biological Chemistry, 269, 23236-23249.
96. Franklin MA, Penn SG, Lebrilla CB, Lam TH, Pessah IN, Molinski TF. (1996) Bastadin 20 and bastadin O-sulfate esters from Ianthella basta: novel modulators of the Ry1R FKBP12 receptor complex. Journal of Natural Products, 59, 1121-1127.
97. Chen L, Molinski TF, Pessah IN. (1999) Bastadin 10 stabilizes the open conformation of the ryanodine-sensitive Ca2+ channel in an FKBP12-dependent manner. Journal of Biological Chemistry, 274, 32603-32612.
98. Zieminska E, Stafiej A, Pitsinos EN, Couladouros EA, Moutsos V, Kozlowska H, Toczylowska B, Lazarewicz JW. (2007) Synthetic bastadins modify the activity of ryanodine receptors in cultured cerebellar granule cells. Neurosignals, 15, 283-292.
99. Zieminska E, Lazarewicz JW, Couladouros EA, Moutsos VI, Pitsinos EN. (2008) Open-chain half-bastadins mimic the effects of cyclic bastadins on calcium homeostasis in cultured neurons. Bioorganic & Medicinal Chemistry Letters, 18, 5734-5737.
100. Miao S, Andersen RJ, Allen TM. (1990) Cytotoxic metabolites from the sponge Lanthella basta collected in Papua New Guinea. Journal of Natural Products, 53, 1441-1446.
101. Carney JR, Scheuer PJ, Kelly-Borges M. (1993) A new bastadin from the sponge Psammaplysilla purpurea. Journal of Natural Products, 56, 153-157.
102. Greve H, Kehraus S, Krick A, Kelter G, Maier A, Fiebig HH, Wright AD, Knig GM. (2008) Cytotoxic bastadin 24 from the Australian sponge Ianthella quadrangulata. Journal of Natural Products, 71, 309-312.
103. Calcul L, Inman WD, Morris AA, Tenney K, Ratnam J, McKerrow JH, Valeriote FA, Crews P. (2010) Additional insights on the bastadins: Isolation of analogues from the sponge Ianthella cf. Reticulata and exploration of the oxime configurations. Journal of Natural Products, 73, 365-372.
104. Aoki S, Cho SH, Ono M, Kuwano T, Nakao S, Kuwano M, Nakagawa S, Gao JQ, Mayumi T, Shibuya M., Kobayashi M. (2006) Bastadin 6, a spongean brominated tyrosine derivative, inhibits tumor angiogenesis by inducing selective apoptosis to endothelial cells. Anti-Cancer Drugs, 17, 269-278.
105. Kotoku N, Hiramatsu A, Tsujita H, Hirakawa Y, Sanagawa M, Aoki S, Kobayashi M. (2008) Structure activity relationships study of bastadin 6, an anti angiogenic brominated tyrosine derived metabolite from marine sponge. Archiv der Pharmazie, 341, 568-577.
106. Mathieu V, Wauthoz N, Lefranc F, Niemann H, Amighi K, Kiss R, Proksch P. (2013) Cyclic versus hemi-bastadins. Pleiotropic anti-cancer effects: from apoptosis to anti-Angiogenic and anti-migratory effects. Molecules, 18, 3543-3561.
107. Proksch P. (1999) Chemical defence in marine ecosystems. Annual Plant Reviews, 3, 134-154.
108. Aerts LAM, Van Soest RWM. (1997) Quantification of sponge/coral interactions in a physically stressed reef community, NE Colombia. Marine ecology progress series. Oldendorf, 148, 125-134.
109. Osbourn AE. (1996) Preformed antimicrobial compounds and plant defense against fungal attack. The Plant Cell, 8, 1821.
110. Dickey RW, Bobzin SC, Faulkner DJ, Bencsath FA, Andrzejewski D. (1990) Identification of okadaic acid from a Caribbean dinoflagellate, Prorocentrum concavum. Toxicon, 28, 371-377.
111. Bialojan C, Takai A. (1988) Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochemical Journal, 256, 283-290.
112. Lee MJ, Jeong DY, Kim WS, Kim HD, Kim CH, Park WW, Park YH, Kim KS, Kim HM, Kim DS. (2000) A tetrodotoxin-producing Vibrio strain, LM-1, from the puffer fish Fugu vermicularis radiatus. Applied and Environmental Microbiology, 66, 1698-1701.
113. Noguchi T, Jeon JK, Arakawa O, Sugita H, Deguchi Y, Shida Y, Hashimoto K. (1986) Occurrence of tetrodotoxin and anhydrotetrodotoxin in Vibrio sp. Isolated from the intestines of a xanthid crab, Atergatis floridus. Journal of Biochemistry, 99, 311-314.
114. Finney L, Vogt S, Fukai T, Glesne D. (2009) Copper and angiogenesis: unravelling a relationship key to cancer progression. Clinical and Experimental Pharmacology and Physiology, 36, 88-94.
115. Ntzmann HW, Reyes-Dominguez Y, Scherlach K, Schroeckh V, Horn F, Gacek A, Schmann J, Hertweck C, Strauss J, Brakhage AA. (2011) Bacteria-induced natural product formation in the fungus Aspergillus nidulans requires Saga/Ada-mediated histone acetylation. Proceedings of the National Academy of Sciences, 108, 14282-14287.
116. Baud MGJ, Leiser T, Meyer-Almes FJ, Fuchter M. (2011) New synthetic strategies towards psammaplin A, access to natural product analogues for biological evaluation. Organic & Biomolecular Chemistry, 9, 659-662.
117. Evans BE, Rittle KE, Bock MG, DiPardo RM, Freidinger RM, Whitter WL, Lundell GF, Veber DF, Anderson PS. (1988) Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. Journal of Medicinal Chemistry, 31, 2235-2246.